Literature DB >> 1510191

Oxygen therapy in sickle cell disease.

A Zipursky1, I C Robieux, E J Brown, D Shaw, H O'Brodovich, J D Kellner, M J Coppes, G Koren, N F Olivieri.   

Abstract

The effect of oxygen therapy on the number of irreversibly (ISC) and reversibly (RSC) sickled cells was studied in patients with sickle cell anemia. Inhalation of 50% oxygen in patients who were not in crisis produced a significant fall in RSCs and a lesser fall in ISCs. Twenty-five subjects in sickle cell crisis were chosen at random to receive either oxygen (15 patients) or air (10 patients). Those who received oxygen showed a significant reduction in RSCs, but not in ISCs. No significant change in RSCs or ISCs occurred in the group who received air. Despite the reduction in RSCs in the oxygen-treated group, there was no significant difference between the air and oxygen groups in the duration of severe pain, opioid administration, and hospitalization. It was also observed that crisis was associated with arterial desaturation and a reduction in the number of RSCs. We conclude that, although RSCs may be involved in the pathophysiology of sickle cell crisis, reduction in RSCs by oxygen therapy in these studies did not result in any reduction in the duration of crisis.

Entities:  

Mesh:

Year:  1992        PMID: 1510191     DOI: 10.1097/00043426-199208000-00007

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  6 in total

Review 1.  Sickle cell disease.

Authors:  Martin M Meremikwu; Uduak Okomo
Journal:  BMJ Clin Evid       Date:  2011-02-14

2.  In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse.

Authors:  S H Embury; N Mohandas; C Paszty; P Cooper; A T Cheung
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 3.  Sickle cell disease.

Authors:  Martin M Meremikwu
Journal:  BMJ Clin Evid       Date:  2009-03-27

4.  Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial.

Authors:  Jo Howard; Baba Inusa; Christina Liossi; Eufemia Jacob; Patrick B Murphy; Nicholas Hart; Johanna Gavlak; Sati Sahota; Maria Chorozoglou; Carol Nwosu; Maureen Gwam; Atul Gupta; David C Rees; Swee Lay Thein; Isabel C Reading; Fenella J Kirkham; Man Yeung Edith Cheng
Journal:  Trials       Date:  2015-08-25       Impact factor: 2.279

5.  Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.

Authors:  Josefina Aparecida Pellegrini Braga; Mônica Pinheiro de Almeida Veríssimo; Sara Teresinha Olalla Saad; Rodolfo Delfini Cançado; Sandra Regina Loggetto
Journal:  Rev Bras Hematol Hemoter       Date:  2016-04-08

Review 6.  Perioperative Management of Sickle Cell Disease.

Authors:  Kwame Ofori Adjepong; Folashade Otegbeye; Yaw Amoateng Adjepong
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.